Cargando…
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is frequently diagnosed in the setting of chronic liver disease and cirrhosis. The median survival after diagnosis is dismal. The treatment options that may offer cure are either resection or liver transplantation. Unfortunately most patients are not eligible for eithe...
Autores principales: | Almhanna, Khaldoun, Philip, Philip A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886319/ https://www.ncbi.nlm.nih.gov/pubmed/20616913 |
Ejemplares similares
-
Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
por: Marta, Guilherme Nader, et al.
Publicado: (2021) -
Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Furuse, Junji
Publicado: (2008) -
A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
por: Huang, Shenglan, et al.
Publicado: (2021) -
Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2018) -
Editorial for the series on gastric and gastroesophageal cancer treatment in 2020
por: Almhanna, Khaldoun
Publicado: (2020)